GB9027208D0 - Medicaments - Google Patents

Medicaments

Info

Publication number
GB9027208D0
GB9027208D0 GB909027208A GB9027208A GB9027208D0 GB 9027208 D0 GB9027208 D0 GB 9027208D0 GB 909027208 A GB909027208 A GB 909027208A GB 9027208 A GB9027208 A GB 9027208A GB 9027208 D0 GB9027208 D0 GB 9027208D0
Authority
GB
United Kingdom
Prior art keywords
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909027208A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB909027208A priority Critical patent/GB9027208D0/en
Publication of GB9027208D0 publication Critical patent/GB9027208D0/en
Priority to PCT/GB1991/002218 priority patent/WO1992010180A1/fr
Priority to AU90529/91A priority patent/AU9052991A/en
Priority to JP4501017A priority patent/JPH06503322A/ja
Priority to EP92900446A priority patent/EP0561878A1/fr
Priority to US09/847,120 priority patent/US20010034360A1/en
Priority to US10/021,321 priority patent/US20020068759A1/en
Priority to US10/134,894 priority patent/US20020160985A1/en
Priority to US10/271,177 priority patent/US20030069293A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB909027208A 1990-12-14 1990-12-14 Medicaments Pending GB9027208D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB909027208A GB9027208D0 (en) 1990-12-14 1990-12-14 Medicaments
PCT/GB1991/002218 WO1992010180A1 (fr) 1990-12-14 1991-12-12 Utilisation d'antagoniste de l'angiotensine ii dans le traitement des infarctus
AU90529/91A AU9052991A (en) 1990-12-14 1991-12-12 Use of angiotensin ii antagonist in the treatment of infarction
JP4501017A JPH06503322A (ja) 1990-12-14 1991-12-12 梗塞形成の処置におけるアンジオテンシン2拮抗剤の使用
EP92900446A EP0561878A1 (fr) 1990-12-14 1991-12-12 Utilisation d'antagoniste de l'angiotensine ii dans le traitement des infarctus
US09/847,120 US20010034360A1 (en) 1990-12-14 2001-05-02 Medicament
US10/021,321 US20020068759A1 (en) 1990-12-14 2001-12-12 Medicament
US10/134,894 US20020160985A1 (en) 1990-12-14 2002-04-29 Medicament
US10/271,177 US20030069293A1 (en) 1990-12-14 2002-10-15 Medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027208A GB9027208D0 (en) 1990-12-14 1990-12-14 Medicaments

Publications (1)

Publication Number Publication Date
GB9027208D0 true GB9027208D0 (en) 1991-02-06

Family

ID=10687042

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909027208A Pending GB9027208D0 (en) 1990-12-14 1990-12-14 Medicaments

Country Status (5)

Country Link
EP (1) EP0561878A1 (fr)
JP (1) JPH06503322A (fr)
AU (1) AU9052991A (fr)
GB (1) GB9027208D0 (fr)
WO (1) WO1992010180A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
EP0577025A3 (fr) * 1992-07-01 1998-02-04 Hoechst Aktiengesellschaft Antagonistes du récepteur d'angiotensine-II pour le traitement et la prophylaxie des maladies coronaires du coeur
CN101011390A (zh) 1999-01-26 2007-08-08 诺瓦提斯公司 血管紧张素ⅱ受体拮抗剂在治疗急性心肌梗塞中的应用
CA2360691A1 (fr) * 1999-01-26 2000-08-03 Novartis Ag Utilisation des antagonistes du recepteur d'angiotensine ii dans le traitement de l'infarctus aigu du myocarde
US6552033B1 (en) 2000-05-16 2003-04-22 The Procter & Gamble Co. Imidazo-containing heterocyclic compounds, their compositions and uses
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2930674A1 (fr) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (fr) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonistes de la guanylate cyclase et leurs utilisations
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0241201A3 (fr) * 1986-04-07 1990-05-23 Merck & Co. Inc. Inhibiteurs de l'enzyme de conversion de l'angiotensine, utiles pour prolonger la survie des mammifères avec un défaut cardiaque congestif
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
EP0955294B1 (fr) * 1989-06-14 2003-09-24 Smithkline Beecham Corporation Acides imidazoalcénoiques
CA2018443A1 (fr) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Acides imidazolyl-alkenoiques
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof

Also Published As

Publication number Publication date
JPH06503322A (ja) 1994-04-14
WO1992010180A1 (fr) 1992-06-25
EP0561878A1 (fr) 1993-09-29
AU9052991A (en) 1992-07-08

Similar Documents

Publication Publication Date Title
GB9026998D0 (en) Medicaments
GB9012469D0 (en) Medicaments
CY2134B1 (en) Medicaments
AP9200403A0 (en) Medicaments
GB9027211D0 (en) Medicaments
GB9027210D0 (en) Medicaments
GB9027200D0 (en) Medicaments
GB9027212D0 (en) Medicaments
GB9027208D0 (en) Medicaments
GB9027199D0 (en) Medicaments
GB9027198D0 (en) Medicaments
GB9027197D0 (en) Medicaments
GB9027209D0 (en) Medicaments
GB9027201D0 (en) Medicaments
GB9104650D0 (en) Medicaments
GB9108348D0 (en) Medicaments
GB9016612D0 (en) Medicaments
GB9024363D0 (en) Medicaments
GB9011940D0 (en) Medicaments
GB9024962D0 (en) Medicaments
GB9022016D0 (en) Medicaments
GB9016951D0 (en) Medicaments
GB9016950D0 (en) Medicaments
GB9024367D0 (en) Medicaments
GB9009067D0 (en) Medicaments